Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T10172 | 5-Iodo-indirubin-3'-monoxime
5-碘靛红-3'-单肟
|
331467-03-9 | 98% |
|
5-Iodo-indirubin-3'-monoxime 是一种 GSK-3β、CDK5/P25和CDK1/cyclin B 抑制剂,IC50值分别为 9、20 和 25 nM,与 ATP 竞争性地结合酶的催化位点。 | ||||
T13309 | Voruciclib hydrochloride
化合物 T13309
|
1000023-05-1 | 98% |
|
Voruciclib hydrochloride is an orally active and selective inhibitor of CDK (Ki: 0.626 nM-9.1 nM). | ||||
TMA1743 | Ergosterol peroxide
过氧麦角甾醇
|
2061-64-5 | 98% |
|
Ergosterol peroxide is an inhibitor of osteoclast differentiation, which has antiviral, trypanocidal, antitumor, and antiangiogenic actions, it can stimulate Fox... | ||||
T72507 | Palbociclib orotate
化合物 Palbociclib orotate
|
2757498-64-7 | 98% |
|
Palbociclib (PD 0332991) orotate 是一种口服活性的CDK4和CDK6选择性抑制剂,其IC50值分别为11 nM和16 nM。该化合物对癌细胞展示出抗增殖效果,并促使细胞周期处于阻滞状态。该药物适用于HR阳性、HER2阴性乳腺癌以及肝细胞癌的研究。 | ||||
T74852 | PROTAC CDK9 degrader-6
化合物 PROTAC CDK9 degrader-6
|
2935587-91-8 | 98% |
|
PROTACCDK9 degrader-6 是靶向CDK9的特异性PROTAC分子,能通过蛋白酶体介导的机制实现CDK9的降解。该化合物针对CDK942与CDK955异构体的DC50分别为0.03 μM和0.05 μM。 | ||||
T2082 | CDK4-IN-1
化合物CDK4-IN-1
|
1256963-02-6 | 98% |
|
CDK4-IN-1 是一种新型的特异性 CDK4/Cyclin D1 抑制剂,IC50 为 10 nM;分别是 CDK1/Cyclin B (IC50>15 uM) 和 CDK2/Cyclin A (IC50=5.265 uM) 的 1500 倍和 500 倍。 | ||||
T13627 | CP-10
化合物 T13627
|
2366268-80-4 | 98% |
|
CP-10 is a PROTAC with highly selective and remarkable CDK6 degradation (DC50: 2.1 nM). It inhibits the proliferation of several hematopoietic cancer cells inclu... | ||||
T10724 | Cdc7-IN-1
化合物 T10724
|
1402055-25-7 | 98% |
|
Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and e... | ||||
T67780 | AM5992
化合物AM5992
|
1169694-98-7 | 98% |
|
AM5992 (化合物195) 是有效的CDK4和CDK6抑制剂(CDK4,IC50=0.013μM)。AM5992可用于CDK4介导的疾病的研究。 | ||||
TN4411 | Lappaol F
化合物 TN4411
|
69394-17-8 | 98% |
|
1. Lappaol F has antioxidant and antiaging properties, it may promote the C. elegans longevity and stress resistance through a JNK-1-DAF-16 cascade. 2. Lap... |
||||
TN3719 | Cristacarpin
化合物 TN3719
|
74515-47-2 | 98% |
|
Cristacarpin exhibits moderate but selective activity towards DNA repair-deficient yeast mutants. It promotes endoplasmic reticulum (ER) stress, leading to sub-l... | ||||
T11345 | Lerociclib
化合物 T11345
|
1628256-23-4 | 98% |
|
Lerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of 2nM, 1 nM for CDK6/CyclinD3 and CDK4/CyclinD1, respectively. | ||||
T11632 | IIIM-290
化合物 T11632
|
2213468-64-3 | 98% |
|
IIIM-290 is an oral CDK inhibitor (IC50s: 90 and 94 nM for CDK2/A and CDK9/T1). | ||||
T10747 | CDK9-IN-9
化合物 T10747
|
2246956-84-1 | 98% |
|
CDK9-IN-9 is a potent and selective CDK9 inhibitor (IC50: 1.8 nM) with anti-cancer activity. It inhibits CDK2 (IC50: 155 nM). | ||||
T12552 | PROTAC CDK2/9 Degrader-1
化合物 T12552
|
2408641-24-5 | 98% |
|
PROTAC CDK2/9 Degrader-1 is a potent CDK2 and CDK9 dual degrader(DC50 of 62 nM and 33 nM). | ||||
T10741 | CDK9-IN-1
化合物 T10741
|
1415559-43-1 | 98% |
|
CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection (IC50: 39 nM for CDK9/CycT1). | ||||
T14136 | AG-024322
化合物 T14136
|
837364-57-5 | 98% |
|
AG-024322 is a potent ATP-competitive inhibitor of pan-CDK against cell cycle kinases CDK1, CDK2, and CDK4(Ki values in the 1-3 nM range) | ||||
T10743 | CDK9-IN-11
化合物 T10743
|
2748368-15-0 | 98% |
|
CDK9-IN-11 是一种有效的CDK9抑制剂,可作为 PROTAC CDK9 Degrader-1 的配体。 | ||||
TN3247 | 7-O-Prenylscopoletin
化合物 TN3247
|
13544-37-1 | 98% |
|
7-O-Prenylscopoletin and cedrelopsin show high antiproliferative activities against cancer cell lines. | ||||
T14990 | CDK12-IN-3
化合物 T14990
|
2220184-50-7 | 98% |
|
CDK12-IN-3 is a selective CDK12 inhibitor (IC50: 491 nM in an enzymatic assay). |